Cognitive & Nootropic

Cognitive & Nootropic Research Peptides

The cognitive and nootropic category contains research peptides studied in neuroscience, brain-derived neurotrophic factor (BDNF) pathway research, attention and cognitive function research models, and neuroprotection studies. Several compounds in this category have research literature from Russian and Eastern European research institutions.

Compounds in this category

• Semax — Synthetic heptapeptide derived from the N-terminal region of adrenocorticotropic hormone (ACTH). Substantial research literature from Russian institutions dating to the 1980s.
• Selank — Synthetic seven-amino-acid peptide based on the immunomodulatory tetrapeptide tuftsin. Studied in anxiolytic and cognitive research contexts.
• Cerebrolysin — Mixture of low-molecular-weight neuropeptides and amino acids derived from porcine brain proteins. Studied in neurodegeneration research models.
• Dihexa — Synthetic hexapeptide studied in synaptic formation research.

Research applications

The compounds in this category are studied in: neurotrophic factor expression research, BDNF and NGF pathway studies, ischemia and neuroprotection research models, learning and memory research in animal models, anxiolytic mechanism research, and synaptic plasticity studies. Research interest in this category has grown notably since the early 2000s as more Western researchers have accessed translated Russian literature.

Quality standards at VialPepLab

Every batch is HPLC-verified to ≥99% purity with LC-MS identity confirmation. Cerebrolysin is verified by amino acid composition analysis given its mixture nature. All single-compound peptides (Semax, Selank, Dihexa) document the standard purity and identity on COAs.

All compounds in this category are sold strictly for in-vitro laboratory research. Not for human or veterinary use.